Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
02/29/2012
Trade Name:
FluMist Quadrivalent
Generic or Proper Name (*):
Influenza Vaccine Live, Intranasal*
Indications Studied:
Active immunization for the prevention of disease caused by influenza
Therapeutic Category:
Vaccine
Ages Studied:
2 - 17 years
Study #:
1
Study Type:
Efficacy/Safety/Immunogenicity
Study Design:
Double-blind
No Patients:
2305
No Centers:
97
No Countries:
1
BPCA(B), PREA(P):
P
Asian:
0
Black:
0
Other:
0
White:
0
Unknown:
0
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
Countries:
0
-
-